Practical Approaches to Clinical Trials in Non-muscle-Invasive Bladder Cancer

Robert S. Svatek, John A. Taylor

Research output: Chapter in Book/Report/Conference proceedingChapter


The randomized controlled trial is a relatively new method for assessing the efficacy of an intervention in the field of urology. Randomized controlled trials address inherent biases through allocation of concealment but are still subject to important biases and limitations. Non-muscle-invasive bladder cancer trials include both adjuvant and non-adjuvant therapeutic trials which have unique outcomes and methodology. Here, we review important biases, endpoints, and aspects of clinical trial design in non-muscle-invasive bladder cancer as well as explore the underpinnings of pivotal trials that changed management for this disease.

Original languageEnglish (US)
Title of host publicationBladder Cancer
Subtitle of host publicationA Practical Guide
PublisherSpringer International Publishing
Number of pages8
ISBN (Electronic)9781484271070
ISBN (Print)9781484271063
StatePublished - Jan 1 2021


  • Bias
  • Bladder cancer
  • Randomized
  • Trial

ASJC Scopus subject areas

  • General Medicine


Dive into the research topics of 'Practical Approaches to Clinical Trials in Non-muscle-Invasive Bladder Cancer'. Together they form a unique fingerprint.

Cite this